These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37407093)

  • 21. Detection of Weak Organic Anion-Transporting Polypeptide 1B Inhibition by Probenecid with Plasma-Based Coproporphyrin in Humans.
    Zhang Y; Holenarsipur VK; Kandoussi H; Zeng J; Mariappan TT; Sinz M; Shen H
    Drug Metab Dispos; 2020 Oct; 48(10):841-848. PubMed ID: 32723847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of OATP1B (Organic Anion-Transporting Polypeptide) Induction by Rifampin in Cynomolgus Monkeys: Determination Using the Endogenous OATP1B Marker Coproporphyrin and Tissue Gene Expression.
    Zhang Y; Chen C; Chen SJ; Chen XQ; Shuster DJ; Puszczalo PD; Fancher RM; Yang Z; Sinz M; Shen H
    J Pharmacol Exp Ther; 2020 Oct; 375(1):139-151. PubMed ID: 32719071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coproporphyrin I Can Serve as an Endogenous Biomarker for OATP1B1 Inhibition: Assessment Using a Glecaprevir/Pibrentasvir Clinical Study.
    Kalluri HV; Kikuchi R; Coppola S; Schmidt J; Mohamed MF; Bow DAJ; Salem AH
    Clin Transl Sci; 2021 Jan; 14(1):373-381. PubMed ID: 33048456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of Coproporphyrin-I Determination in First-in-Human Study for Early Evaluation of OATP1B Inhibitory Potential Based on Investigation of Ensitrelvir, an Oral SARS-CoV-2 3C-Like Protease Inhibitor.
    Watari R; Sawada H; Hashimoto H; Kasai Y; Oka R; Shimizu R; Matsuzaki T
    J Pharm Sci; 2024 Mar; 113(3):798-805. PubMed ID: 37742997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute and Chronic Effects of Rifampin on Letermovir Suggest Transporter Inhibition and Induction Contribute to Letermovir Pharmacokinetics.
    Robbins JA; Menzel K; Lassman M; Zhao T; Fancourt C; Chu X; Mostoller K; Witter R; Marceau West R; Stoch SA; McCrea JB; Iwamoto M
    Clin Pharmacol Ther; 2022 Mar; 111(3):664-675. PubMed ID: 34888851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substantially Increased Plasma Coproporphyrin-I Concentrations Associated With OATP1B1*15 Allele in Japanese General Population.
    Suzuki Y; Sasamoto Y; Koyama T; Yoshijima C; Nakatochi M; Kubo M; Momozawa Y; Uehara R; Ohno K
    Clin Transl Sci; 2021 Jan; 14(1):382-388. PubMed ID: 32961019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A fully automated and validated human plasma LC-MS/MS assay for endogenous OATP biomarkers coproporphyrin-I and coproporphyrin-III.
    King-Ahmad A; Clemens S; Ramanathan R; Zhang Y; Raha N; Zhang Y; Holliman C; Rodrigues AD; Li F
    Bioanalysis; 2018 May; 10(9):691-701. PubMed ID: 29747517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Various effects of repeated rifampin dosing on coproporphyrin levels in humans.
    Kinzi J; Grube M; Brecht K; Seibert I; Siegmund W; Meyer Zu Schwabedissen HE
    Clin Transl Sci; 2023 Nov; 16(11):2289-2298. PubMed ID: 37705216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin.
    Prueksaritanont T; Chu X; Evers R; Klopfer SO; Caro L; Kothare PA; Dempsey C; Rasmussen S; Houle R; Chan G; Cai X; Valesky R; Fraser IP; Stoch SA
    Br J Clin Pharmacol; 2014 Sep; 78(3):587-98. PubMed ID: 24617605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic Account of Distinct Change in Organic Anion Transporting Polypeptide 1B (OATP1B) Substrate Pharmacokinetics during OATP1B-Mediated Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling.
    Hegde PV; Morse BL
    Drug Metab Dispos; 2024 Jul; 52(8):886-898. PubMed ID: 38740464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive correlation between organic anion transporter 1B function indicated by plasma concentration of coproporphyrin-I and blood concentration of cyclosporin A in real-world patients.
    Watanabe T; Tanaka R; Suzuki Y; Sato H; Negami J; Yoshijima C; Oda A; Ono H; Tatsuta R; Ohno K; Itoh H
    Br J Clin Pharmacol; 2023 May; 89(5):1672-1681. PubMed ID: 36517987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of Prediction Methods for Drug-Drug Interactions Based on the Construction of Physiologically Based Pharmacokinetic Models for Hepatic OATP Substrate Drugs and Endogenous Substrates].
    Yoshikado T
    Yakugaku Zasshi; 2023; 143(1):11-19. PubMed ID: 36596534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologically-based pharmacokinetic model-based translation of OATP1B-mediated drug-drug interactions from coproporphyrin I to probe drugs.
    Mochizuki T; Aoki Y; Yoshikado T; Yoshida K; Lai Y; Hirabayashi H; Yamaura Y; Rockich K; Taskar K; Takashima T; Chu X; Zamek-Gliszczynski MJ; Mao J; Maeda K; Furihata K; Sugiyama Y; Kusuhara H
    Clin Transl Sci; 2022 Jun; 15(6):1519-1531. PubMed ID: 35421902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanded Physiologically-Based Pharmacokinetic Model of Rifampicin for Predicting Interactions With Drugs and an Endogenous Biomarker via Complex Mechanisms Including Organic Anion Transporting Polypeptide 1B Induction.
    Asaumi R; Menzel K; Lee W; Nunoya KI; Imawaka H; Kusuhara H; Sugiyama Y
    CPT Pharmacometrics Syst Pharmacol; 2019 Nov; 8(11):845-857. PubMed ID: 31420941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic.
    Yadav AS; Stevison F; Kosaka M; Wong S; Kenny JR; Amory JK; Isoherranen N
    Drug Metab Dispos; 2022 Jul; 50(7):1042-1052. PubMed ID: 35545255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A highly selective and sensitive LC-MS/HRMS assay for quantifying coproporphyrins as organic anion-transporting peptide biomarkers.
    Ramanathan R; King-Ahmad AJ; Holliman CL; Rodrigues AD
    Bioanalysis; 2017 Nov; 9(22):1787-1806. PubMed ID: 28978230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PBPK Modeling of Coproporphyrin I as an Endogenous Biomarker for Drug Interactions Involving Inhibition of Hepatic OATP1B1 and OATP1B3.
    Yoshikado T; Toshimoto K; Maeda K; Kusuhara H; Kimoto E; Rodrigues AD; Chiba K; Sugiyama Y
    CPT Pharmacometrics Syst Pharmacol; 2018 Nov; 7(11):739-747. PubMed ID: 30175555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Evaluation of the Utility of 20 Endogenous Molecules as Biomarkers of OATP1B Inhibition Compared with Rosuvastatin and Coproporphyrin I.
    Barnett S; Ogungbenro K; Ménochet K; Shen H; Humphreys WG; Galetin A
    J Pharmacol Exp Ther; 2019 Jan; 368(1):125-135. PubMed ID: 30314992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of Chimeric Mice with Humanized Livers for Predicting Hepatic Organic Anion-Transporting Polypeptide 1B-Mediated Clinical Drug-Drug Interactions.
    Feng B; Liang G; Zetterberg C; Li S; Huang H; Williams J; Gao H; Morikawa Y; Kumar S
    Drug Metab Dispos; 2024 Sep; 52(10):1073-1082. PubMed ID: 39103225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dehydroepiandrosterone sulfate, a useful endogenous probe for evaluation of drug-drug interaction on hepatic organic anion transporting polypeptide (OATP) in cynomolgus monkeys.
    Watanabe M; Watanabe T; Yabuki M; Tamai I
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):198-204. PubMed ID: 25989893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.